Overall, lymphocyte subset levels in MMP-3 negative RA patients were higher than those in MMP-3 positive RA patients, especially CD19+ B cells, NK cells, Th17 cells, and Treg cells. This evidence concerns the gene CD19 and rheumatoid arthritis.